Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
Standard
Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study. / Montalban, X; Comi, G; O'Connor, P; Gold, Stefan; de Vera, A; Eckert, B; Kappos, L.
in: MULT SCLER J, Jahrgang 17, Nr. 11, 11, 2011, S. 1341-1350.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
AU - Montalban, X
AU - Comi, G
AU - O'Connor, P
AU - Gold, Stefan
AU - de Vera, A
AU - Eckert, B
AU - Kappos, L
PY - 2011
Y1 - 2011
N2 - Health-related quality of life (HRQoL) worsens with multiple sclerosis (MS) relapses and disease progression. Common symptoms including depression and fatigue may contribute to poor HRQoL.
AB - Health-related quality of life (HRQoL) worsens with multiple sclerosis (MS) relapses and disease progression. Common symptoms including depression and fatigue may contribute to poor HRQoL.
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Psychiatric Status Rating Scales
KW - Questionnaires
KW - Treatment Outcome
KW - Europe
KW - Time Factors
KW - Double-Blind Method
KW - Placebos
KW - Chi-Square Distribution
KW - Administration, Oral
KW - Quality of Life
KW - Canada
KW - Depression/drug therapy/etiology
KW - Immunosuppressive Agents/administration & dosage
KW - Multiple Sclerosis, Chronic Progressive/diagnosis/drug therapy/psychology
KW - Multiple Sclerosis, Relapsing-Remitting/diagnosis/drug therapy/psychology
KW - Propylene Glycols/administration & dosage
KW - Sphingosine/administration & dosage/analogs & derivatives
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Psychiatric Status Rating Scales
KW - Questionnaires
KW - Treatment Outcome
KW - Europe
KW - Time Factors
KW - Double-Blind Method
KW - Placebos
KW - Chi-Square Distribution
KW - Administration, Oral
KW - Quality of Life
KW - Canada
KW - Depression/drug therapy/etiology
KW - Immunosuppressive Agents/administration & dosage
KW - Multiple Sclerosis, Chronic Progressive/diagnosis/drug therapy/psychology
KW - Multiple Sclerosis, Relapsing-Remitting/diagnosis/drug therapy/psychology
KW - Propylene Glycols/administration & dosage
KW - Sphingosine/administration & dosage/analogs & derivatives
M3 - SCORING: Journal article
VL - 17
SP - 1341
EP - 1350
JO - MULT SCLER J
JF - MULT SCLER J
SN - 1352-4585
IS - 11
M1 - 11
ER -